FINWIRES · TerminalLIVE
FINWIRES

Canada's Spring Budget Update Shows Government to Spend The Savings, UBS Says

作者

-- The government of Canada on Tuesday released its spring economic update, with the revised projections for the fiscal deficit in 2025-26 down about $2 billion to around $67 billion, or roughly 2.1% of gross domestic product relative to the 2.5% prior, said UBS.

That still implies a widening of the deficit of 0.9 percentage point of GDP relative to the 2024-25 fiscal year and the deficit is expected to remain wide at 1.9% of GDP in fiscal year 2026-27 and 1.8% in FY 2027-28, writes the bank in a note to clients.

The better deficit outlook for FY2025-26 reflects a combination of stronger growth and revenues on the basis of higher oil prices, but also a reassessment of the rollout expected from several programs in the coming years, stated UBS.

This includes revised allowances for liabilities for natural disasters, and revised timing for uptake of Clean Economy investment tax credits and electric vehicle battery manufacturing supports.

With the slower expected spend out, the bank marks down its expectation for support from fiscal this year by a tenth, and adds a little into next year and 2028. This leaves the UBS expectations for real GDP growth at 1.5% for this year, 1.7% in 2027 and 1.8% in 2028.

Fiscal actions since Budget 2025 and incorporating the Spring Economic Update are estimated to cost about $55 billion over the next six years, with around $38 billion of this coming from this week's update.

The majority of the new spending is roughly $25 billion over the next three years on a cash basis, earmarked to launch a Canadian sovereign wealth fund -- the "Canada Strong Fund" -- and a smaller roughly $6 billion allocated to boost the skills of young workers and to support building out the supply of housing.

相關文章

Australia

Leerink Partners 將 Labcorp 的目標價從 347 美元下調至 340 美元。

根據FactSet調查的分析師報告,Labcorp (LH) 的平均評級為“增持”,平均目標價為311.35美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $257.19, Change: $+0.05, Percent Change: +0.02%

$LH
Australia

午盤漲幅最大的股票

臨床階段製藥公司Avalyn Pharma (AVLN)週三晚間宣布,已將其規模擴大的首次公開募股(IPO)定價為每股18美元,發行約1,670萬股,目標募集資金約3億美元。 該股在納斯達克上市首日便大幅上漲,午後交易時段漲幅超過50%,達到約27.44美元,盤中成交量超過365萬股。 Everspin Technologies (MRAM)週四宣布與美國主要承包商達成協議,將為美國國防工業基地客戶提供Toggle MRAM製程技術和工程服務。該協議價值4000萬美元,有效期為兩年半。 該股盤中成交量從日均約53.3萬股飆升至超過1,260萬股,漲幅高達37%。 Viavi Solutions (VIAV) 股價上漲 15%,此前該公司公佈的第三財季業績和第四財季業績指引均超出市場預期。 當日成交量超過 1,510 萬股,而每日平均成交量約 587 萬股。Price: $27.00, Change: $+9.00, Percent Change: +50.00%

$AVLN$MRAM$VIAV
Australia

Argus將納斯達克目標股價從98美元上調至103美元。

根據FactSet調查的分析師數據,納斯達克(NDAQ)的平均評級為“買入”,平均目標價為110.06美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $91.63, Change: $+0.36, Percent Change: +0.40%

$NDAQ